ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• The Future Of Data Linkage In Clinical Trial Evidence Generation

  Explore key questions about the future of AI and data linkage in clinical trial evidence generation.

• Opportunities For Enhancing Signal Detection In Schizophrenia Trials

  Signal detection in schizophrenia trials is hindered by increased placebo response, complex rating scales, inconsistent rater performance, and data quality issues.

• How Paper And Electronic Source Data Meet ALCOA-C Principles

  According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective. 

• Outsourcing Data Management: Challenges And Benefits

  Life sciences companies are grappling with a deluge of data. Yet strategic data management outsourcing offers potential benefits amidst regulatory and interoperability hurdles.

• A Blueprint For Modern Obesity Research

  The landscape of obesity and GLP-1 research has reached a saturation point. To successfully scale to the 5,000-patient registries now required for long-term evidence, a shift in operational architecture is essential.

• Evaluating Wearable Data Platforms For Endpoint-Driven Studies

  Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.

• Drive Superior Enrollment, Speed, And Quality Using eSource

  Explore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.

• Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals

  Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

• Standardize Vaccine Study Launch Timelines To Just 5 Weeks

  Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.

• Bringing Expertise To Clinical Trials

  Discover how Veristat achieved improved efficiency and enhanced control over its clinical trials.